Design, Synthesis and Biological Evaluation of Novel SN38 Based Albumin-Binding Peptide–Drug Conjugates in Pancreatic Ductal Adenocarcinoma

Yi Su, Yingxin Lu, Jiahui Yu, Chen Jin, Yi Chen, Wei Lu, Jian Ding

Open source

DOI
10.3390/pharmaceutics18081028
Published
2026-08-19
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics18081028,
  title = {Design, Synthesis and Biological Evaluation of Novel SN38 Based Albumin-Binding Peptide–Drug Conjugates in Pancreatic Ductal Adenocarcinoma},
  author = {Yi Su and Yingxin Lu and Jiahui Yu and Chen Jin and Yi Chen and Wei Lu and Jian Ding},
  year = {2026},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics18081028},
  url = {https://doi.org/10.3390/pharmaceutics18081028}
}

RIS

TY  - JOUR
TI  - Design, Synthesis and Biological Evaluation of Novel SN38 Based Albumin-Binding Peptide–Drug Conjugates in Pancreatic Ductal Adenocarcinoma
AU  - Yi Su
AU  - Yingxin Lu
AU  - Jiahui Yu
AU  - Chen Jin
AU  - Yi Chen
AU  - Wei Lu
AU  - Jian Ding
PY  - 2026
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18081028
UR  - https://doi.org/10.3390/pharmaceutics18081028
ER  - 

APA

Su, Y., Lu, Y., Yu, J., Jin, C., Chen, Y., Lu, W., & Ding, J. (2026). Design, Synthesis and Biological Evaluation of Novel SN38 Based Albumin-Binding Peptide–Drug Conjugates in Pancreatic Ductal Adenocarcinoma. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18081028

Source records